Exact Mass: 482.2681624
Exact Mass Matches: 482.2681624
Found 124 metabolites which its exact mass value is equals to given mass value 482.2681624
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Gentamicin X2
C19H38N4O10 (482.25878079999995)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins
Alectinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01ED - Anaplastic lymphoma kinase (alk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C141136 - ALK Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Cilobradine
Gentamicin B
C19H38N4O10 (482.25878079999995)
3-Me ether-22beta-2,3,22,23-Tetrahydroxy-24,29-dinor-1,3,5(10),7-friedelatetraene-6,21-dione|3-methyl-22beta,23-dihydroxy-6-oxo-tingenol
7alpha-(acetoxy)-23xi-methoxy-21,23-epoxy-24,25,26,27-tetranorapotirucalla-1,14,20(22)-trien-3,21-dione|O-methylazadironolide
11,12-epoxy-2,6-dihydroxy-24-norursa-1,4-dien-3-on-(28->13)-olide|2,6beta-dihydroxy-3-oxo-11alpha,12alpha-epoxy-24-norursa-1,4-dien-28,13beta-olide
(5S,10S,13R,16R,17S,20S,22R,23S,24S)-16,22-epoxy-21,23-lactone-24-hydroxystigmasta-8,14-dien-3,28-dione|vernoanthelcin C
(4aS,6aS,6bR,8R,12aS,12bS,12cS,13aS,13bS,13cR)-1,3,4,5,6,6a,6b,7,8,12a,12b,12c,13a,13c-tetradecahydro-8,11-dihydroxy-2,2,6a,6b,9,12a-hexamethyl-2H,10H-13b,4a-(epoxymethano)piceno[13,14-b]oxirene-10,15-dione|2,6beta-dihydroxy-3-oxo-11alpha,12alpha-epoxy-24-noroleana-1,4-dien-28,13beta-olide|asprellol C
Blepharotriol
Blepharotriol is a natural product found in Maytenus woodsonii with data available.
(5E,9Z,24Z)-6-bromoheptacosa-5,9,24-trienoic acid
C27H47BrO2 (482.27592219999997)
His Ala Gln Lys
C29H38O6_(7alpha,9xi,13alpha,17alpha)-17-(5-Methoxy-2-oxo-2,5-dihydro-3-furanyl)-4,4,8-trimethyl-3-oxoandrosta-1,14-dien-7-yl acetate
Ala His Lys Gln
Ala His Gln Lys
Ala Lys His Gln
Ala Lys Gln His
Ala Gln His Lys
Ala Gln Lys His
His Ala Lys Gln
His Lys Ala Gln
His Lys Gln Ala
His Gln Ala Lys
His Gln Lys Ala
Lys Ala His Gln
Lys Ala Gln His
Lys His Ala Gln
Lys His Gln Ala
Lys Gln Ala His
Lys Gln His Ala
Asn Pro Pro Arg
Asn Pro Arg Pro
Asn Arg Pro Pro
Pro Asn Pro Arg
Pro Asn Arg Pro
Pro Pro Asn Arg
Pro Pro Arg Asn
Pro Arg Asn Pro
Pro Arg Pro Asn
Gln Ala His Lys
Gln Ala Lys His
Gln His Ala Lys
Gln His Lys Ala
Gln Lys Ala His
Gln Lys His Ala
Arg Asn Pro Pro
Arg Pro Asn Pro
Arg Pro Pro Asn
Gentamicin B
C19H38N4O10 (482.25878079999995)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic
(2R,3S,4R,5R,6S)-5-amino-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-5-[(1R)-1-aminoethyl]-3,4-dihydroxyoxolan-2-yl]oxy-3-hydroxycyclohexyl]oxy-2-[(1R)-1-hydroxyethyl]oxane-3,4-diol
C19H38N4O10 (482.25878079999995)
Alectinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01ED - Anaplastic lymphoma kinase (alk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C141136 - ALK Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (E)-hexadec-3-enoate
[(2R)-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] hexadec-9-enoate
[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (E)-hexadec-9-enoate
[3-carboxy-2-[(4Z,8E,10E,12E)-17-carboxy-7,14-dihydroxyheptadeca-4,8,10,12-tetraenoyl]oxypropyl]-trimethylazanium
C25H40NO8+ (482.27537800000005)
[(1S)-7-methoxy-9-methyl-1-[[4-(2-pyridinyl)phenyl]methyl]-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
[(1R)-7-methoxy-9-methyl-1-[[4-(2-pyridinyl)phenyl]methyl]-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
2-methylpropyl N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
2-methylpropyl N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(2-fluorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2S,3R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(2-fluorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2R,3R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(3-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2S,3R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(3-fluorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2S,3R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(4-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(4-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
2-methylpropyl N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
2-methylpropyl N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
2-methylpropyl N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
2-methylpropyl N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(4-fluorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2R,3R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(2-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2S,3R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(2-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(2-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2R,3R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(3-fluorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2S,3R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(3-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(3-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2S,3S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(4-fluorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2R,3R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(4-fluorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2S,3S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(4-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2S,3R)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(4-fluorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
2-methylpropyl N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
(2S,3S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(3-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-2-[[(3-fluorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35FN4O3 (482.26930519999996)
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-hexadec-9-enoate
1-(9Z-hexadecenoyl)-glycero-3-phospho-(1-sn-glycerol)
decyl beta-D-maltopyranoside
C22H42O11 (482.27269820000004)
A glycoside resulting from attachment of a decyl group to the reducing-end anomeric centre of a beta-maltose molecule.